MedPath

Fertility outcomes following intrauterine injection of human chorionic gonadotropin (HCG) before embryo transfer

Not Applicable
Conditions
Infertility.
inability to achieve a pregnancy sterility, female NOS
Registration Number
IRCT201208058469N2
Lead Sponsor
Vice Chancellor for Research, Tehran University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
200
Inclusion Criteria

All patients younger than 40 years old referred to the infertility clinic of Shariati Hospital and will undergo In vitro fertilization (IVF) for the first time.
Exclusion criteria: Patients with endometriosis, azoospermia, patients with uterine fibroids or history of myomectomy, and patients with hydrosalpingitis

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Pregnancy. Timepoint: 4 weeks after embryo transfer. Method of measurement: detection of fetal heart rate in trans vaginal sonography.
Secondary Outcome Measures
NameTimeMethod
Implantation rate. Timepoint: 3 weeks after embryo transfer. Method of measurement: number of gestational sacs in trans vaginal sonography to the number of embryos transferred in each cycle.;Ongoing pregnancy. Timepoint: continuation of pregnancy in 20 weeks. Method of measurement: sonography.;Abortion. Timepoint: before 20 weeks. Method of measurement: sonography.;Multiple pregnancy. Timepoint: 4 weeks after embryo transfer. Method of measurement: more than one sac containing fetal heart in sonography.;Ectopic pregnancy. Timepoint: 4 weeks after embryo transfer. Method of measurement: sonography.
© Copyright 2025. All Rights Reserved by MedPath